CLINICAL_TRIALS
trial_result
· 2007-03-05
Clinical Trial Update: Treatment of Patients With Type 2 Diabetes With an Interleukin-1 Antagonist [Phase 2]
Summary
A Phase 2 clinical trial evaluating an interleukin-1 antagonist in patients with type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Type 2 Diabetes | Phase 2 | Status: COMPLETED